DuPont announced it has completed construction on a new probiotics fermentation unit at its Rochester, NY facility. It also mentioned that it is on track to increase the probiotics capacity by 70 percent.
The multi-phased unit, now largest in the world, is part of a nearly $100 million investment to expand probiotics capacity and enhance the company’s clinically documented probiotics to dietary supplement and food and beverage manufacturers.
The company stated, “The fermentation unit is fully operational and will serve as a crucial resource in propagating bacteria and enabling high potency, stability and efficacy of probiotics.”
Matthias Heinzel, President, DuPont Nutrition & Health said, “Completing the construction on our new fermentation unit marks a major milestone in delivering essential innovations for our customers and achieving our ambitious probiotics growth plans. Today, we are witnessing a significant rise in demand for probiotics as consumers make health and wellness a daily priority. We are proud to continue to deliver on our commitment to invest in this fast-growing segment, which can also enable sustainable growth for our customers around the world.”
In addition, the company announced that DuPont has also completed a probiotics capacity expansion at its Madison, Wisconsin, facility in late 2018. The investment was used to upgrade equipment and increase the pace of new product development and significantly improved delivery times on pilot material for clinical trials and customer evaluations.
DuPont offers clinically documented strains with its DuPont Danisco portfolio to support digestive health, immune health, women’s health and other areas. The company is also leveraging its probiotics platform for the development of human milk oligosaccharides (HMOs) as part of a larger microbiome investment strategy.